Exploring the combination with azacitidineStudy led by Medical College of Wisconsin MADRID and CAMBRIDGE, Mass., Jan. 23, 2025 (GLOBE NEWSWIRE) ...

Exploring the combination with azacitidineStudy led by Medical College of Wisconsin MADRID and CAMBRIDGE, Mass., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY) ...

The results were presented in a poster entitled "Preclinical evaluation ... tumors at the European Society of Medical Oncology (ESMO) Congress, being held in Barcelona from 13-17 September 2024.

We also monitored the social media activity and influence of the 28 ESMO Ambassadors, who kept their followers abreast of the latest scientific advancements at ESMO by posting collectively 1,710 ...

In addition to this, we also assessed the prognostic values of these alterations, and specifically in the HER2-positive breast cancer brain metastasis, we observed that the presence of PIK3CA ...

NCI investigator John Haanen told the ESMO congress that TIL therapy improved PFS compared to Yervoy by 50%, 7.2 months versus 3.1 months with Yervoy, which was a significant improvement.

Join us in welcoming the Year of the Snake on Saturday, January 25, 2025. Ring in the new year with performances and craft activities inspired by Lunar New Year traditions across Asia, including lion ...

The data were presented at a poster session of the 66th American Society of Hematology Annual Meeting in San Diego, California. Of the 23 efficacy evaluable patients in the mon • PRT2527 ...

Researchers at University of California San Diego School of Medicine have published results that shed new light on an old question: what causes aging at the molecular level? Their findings ...

Duke clinicians and patients discuss how approaches such as talk, music, and art therapy can address psychosocial issues that cancer survivors often face. Beyond Cancer: Building Bridges Experts ...

Senior Adviser, European Policy Centre, Adjunct Professor, Hertie School of Governance, Berlin This essay examines the state of the European Union post-eurozone crisis, and assesses the European ...

ESMO 2024: Clinical Prognostic Factors Within the High-Volume Subgroup of Metastatic Hormone Sensitive Prostate Cancer in ENZAMET (ANZUP 1304) ESMO 2024: HARMONY: A Phase II Study of ...